B-Type Natriuretic Peptide Can Predict the Medium-Term Risk in Patients With Acute Heart Failure and Preserved Systolic Function
- 30 September 2005
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 11 (7) , 498-503
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A ReviewClinical Chemistry, 2004
- Burden of Systolic and Diastolic Ventricular Dysfunction in the CommunityJAMA, 2003
- B-Type Natriuretic Peptide Levels: Diagnostic and Prognostic in Congestive Heart FailureCirculation, 2002
- B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart FailureCirculation, 2002
- Role of brain natriuretic peptide in risk stratification of patients with congestive heart failureJACC, 2001
- Heart failure with preserved systolic functionJACC, 2001
- A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot studyJACC, 2001
- Epidemiology, aetiology, and prognosis of heart failureHeart, 2000
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997